✦ LIBER ✦

Patient- and caregiver-reported bleeding symptoms and reasons for starting and stopping treatment with recombinant factor VIIa: analysis of the Dosing Observational Study in Haemophilia (DOSE)

✍ Scribed by L. A. VALENTINO; C. E. WALSH; M. T. REDING; G. A. YOUNG; O. LEVENDOGLU-TUGAL; D. L. COOPER

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Patient/Caregiver-reported recombinant f

✍ G. YOUNG; A. D. SHAPIRO; C. E. WALSH; R. A. GRUPPO; R. Z. GUT; D. L. COOPER 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

Single-dose (270 μg kg−1) recombinant ac

✍ B. PAN-PETESCH; P. LAGUNA; A. MITAL; J. STANLEY; M. F. TORCHET; S. Z. SALEK; P. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB